166 related articles for article (PubMed ID: 36718510)
1. Ultra-High Performance Liquid Chromatography-Mass Spectrometry-based Serum Metabolomics for Early Diagnosis of Refractory Tumor-induced Osteomalacia: A Case-control Study.
Li X; Gong Y; Zhang Q; Ni X; Pang Q; Chi Y; Jiajue R; Cui L; Jiang X; Wang O; Xing X; Jiang Y; Li M; Xia W
J Clin Endocrinol Metab; 2023 Jul; 108(8):2016-2023. PubMed ID: 36718510
[TBL] [Abstract][Full Text] [Related]
2. Serum Metabolomics Reveals Dysregulation and Diagnostic Potential of Oxylipins in Tumor-induced Osteomalacia.
Gong Y; Ni X; Jin C; Li X; Wang Y; Wang O; Li M; Xing X; Wu Z; Jiang Y; Xia W
J Clin Endocrinol Metab; 2022 Apr; 107(5):1383-1391. PubMed ID: 34904633
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites.
Di Gangi IM; Mazza T; Fontana A; Copetti M; Fusilli C; Ippolito A; Mattivi F; Latiano A; Andriulli A; Vrhovsek U; Pazienza V
Oncotarget; 2016 Feb; 7(5):5815-29. PubMed ID: 26735340
[TBL] [Abstract][Full Text] [Related]
4. Metabolic signatures of hepatolithiasis using ultra-high performance liquid chromatography-tandem mass spectrometry.
Wang C; Yang J; Li E; Luo S; Sun C; Liao Y; Li M; Ge J; Lei J; Zhou F; Wu L; Liao W
Metabolomics; 2022 Aug; 18(9):69. PubMed ID: 35976530
[TBL] [Abstract][Full Text] [Related]
5. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
Gu Y; Zang P; Li J; Yan Y; Wang J
Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
[TBL] [Abstract][Full Text] [Related]
6. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
[TBL] [Abstract][Full Text] [Related]
7. Untargeted LC-HRMS-Based Metabolomics for Searching New Biomarkers of Pancreatic Ductal Adenocarcinoma: A Pilot Study.
Ríos Peces S; Díaz Navarro C; Márquez López C; Caba O; Jiménez-Luna C; Melguizo C; Prados JC; Genilloud O; Vicente Pérez F; Pérez Del Palacio J
SLAS Discov; 2017 Apr; 22(4):348-359. PubMed ID: 27655283
[TBL] [Abstract][Full Text] [Related]
8. Urine and serum metabolomic analysis of endometrial cancer diagnosis and classification based on ultra-performance liquid chromatography mass spectrometry.
Chen J; Lu H; Cao D; Sun J; Qi F; Liu X; Liu J; Yang J; Yu M; Zhou H; Cheng N; Wang J; Zhang Y; Peng P; Wang T; Shen K; Sun W
Metabolomics; 2024 Jan; 20(1):18. PubMed ID: 38281200
[TBL] [Abstract][Full Text] [Related]
9. Integrated biomarker for type 2 diabetes mellitus and impaired fasting glucose based on metabolomics analysis using ultra-high performance liquid chromatography quadrupole-Orbitrap high-resolution accurate mass spectrometry.
Long J; Liu L; Jia Q; Yang Z; Sun Z; Yan C; Yan D
Rapid Commun Mass Spectrom; 2020 Jun; 34(12):e8779. PubMed ID: 32159245
[TBL] [Abstract][Full Text] [Related]
10. Potential metabolomic biomarkers for reliable diagnosis of Behcet's disease using gas chromatography/ time-of-flight-mass spectrometry.
Ahn JK; Kim J; Hwang J; Song J; Kim KH; Cha HS
Joint Bone Spine; 2018 May; 85(3):337-343. PubMed ID: 28549946
[TBL] [Abstract][Full Text] [Related]
11. Metabolomic analysis reveals potential biomarkers and serum metabolomic profiling in spontaneous intracerebral hemorrhage patients using UPLC/quadrupole time-of-flight MS.
Sun G; Jiang F; Hu S; Cheng H; Qu L; Tao Y; Ma B
Biomed Chromatogr; 2022 Jan; 36(1):e5241. PubMed ID: 34505712
[TBL] [Abstract][Full Text] [Related]
12. Urinary metabolomic analysis of intrahepatic cholestasis of pregnancy based on high performance liquid chromatography/mass spectrometry.
Ma L; Zhang X; Pan F; Cui Y; Yang T; Deng L; Shao Y; Ding M
Clin Chim Acta; 2017 Aug; 471():292-297. PubMed ID: 28669684
[TBL] [Abstract][Full Text] [Related]
13. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
14. Dynamic changes of key metabolites during liver fibrosis in rats.
Yu J; He JQ; Chen DY; Pan QL; Yang JF; Cao HC; Li LJ
World J Gastroenterol; 2019 Feb; 25(8):941-954. PubMed ID: 30833800
[TBL] [Abstract][Full Text] [Related]
15. LC-MS-based serum metabolomics reveals a distinctive signature in patients with rheumatoid arthritis.
Li J; Che N; Xu L; Zhang Q; Wang Q; Tan W; Zhang M
Clin Rheumatol; 2018 Jun; 37(6):1493-1502. PubMed ID: 29442259
[TBL] [Abstract][Full Text] [Related]
16. Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics.
Wei Y; Jasbi P; Shi X; Turner C; Hrovat J; Liu L; Rabena Y; Porter P; Gu H
J Proteome Res; 2021 Jun; 20(6):3124-3133. PubMed ID: 34033488
[TBL] [Abstract][Full Text] [Related]
17. Serum metabolite profiling of familial adenomatous polyposis using ultra performance liquid chromatography and tandem mass spectrometry.
Sun L; Kang Q; Pan Y; Li N; Wang X; He Y; Wang H; Yu D; Xie H; Yang L; Lu Y; Jin P; Sheng J
Cancer Biol Ther; 2019; 20(7):1017-1028. PubMed ID: 30983515
[TBL] [Abstract][Full Text] [Related]
18. Nonremission and Recurrent Tumor-Induced Osteomalacia: A Retrospective Study.
Li X; Jiang Y; Huo L; Wu H; Liu Y; Jin J; Yu W; Lv W; Zhou L; Xia Y; Wang O; Li M; Xing X; Chi Y; Jiajue R; Cui L; Meng X; Xia W
J Bone Miner Res; 2020 Mar; 35(3):469-477. PubMed ID: 31643101
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel serum biomarker for the detection of acute myeloid leukemia based on liquid chromatography-mass spectrometry.
Wang D; Tan G; Wang H; Chen P; Hao J; Wang Y
J Pharm Biomed Anal; 2019 Mar; 166():357-363. PubMed ID: 30690249
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
